TLRY
The latest bull thesis
Tilray just got a shiny new vote of confidence from Roth Capital’s Bill Kirk, who thinks the stock could climb more than 40% over the next year. For a name like Tilray, that kind of upside call can feel a little like a dare: exciting, headline-friendly, and very much not the same thing as a signed contract.
Why investors should care
Analyst calls can move cannabis stocks because they’re often starved for catalysts. When one Wall Street voice says, “Hey, maybe this thing isn’t dead money,” traders tend to perk up and lean in.
- A big upside call can juice short-term sentiment
- It can draw attention back to Tilray’s turnaround story
- It does not mean the fundamentals suddenly changed overnight
The fine print
This is still just one analyst’s opinion, and the article doesn’t give a concrete new price target or fresh business update — just a 12-month upside view. So if you’re holding TLRY, this is more “interesting data point” than “mission accomplished.”
Big picture: analyst optimism can be a nice tailwind, but for Tilray, the real test is whether the company can keep proving the story with actual results — not just Wall Street hopium.